AB146193
Thiamet G, O-GlcNAcase inhibitor
Be the first to review this product! Submit a review
|
(2 Publications)
MW 248.3 Da. Potent, selective O-GlcNAcase inhibitor (Ki = 21 nM). Blocks tau phosphorylation. Increases O-GlcNAc-modified protein levels (EC50 = 30 nM). Shows antitauopathic effects in vivo. Orally active. Blood-brain barrier permeable.
1 Images
- Chemical Structure
Lab
Chemical Structure - Thiamet G, O-GlcNAcase inhibitor (AB146193)
2D chemical structure image of ab146193, Thiamet G, O-GlcNAcase inhibitor
Properties and storage information
Shipped at conditions
Ambient - Can Ship with Ice
Appropriate short-term storage conditions
-20°C
Appropriate long-term storage conditions
-20°C
Storage information
Store under desiccating conditions|The product can be stored for up to 12 months
Publications (2)
Recent publications for all applications. Explore the full list and refine your search
Nature communications 15:7430 PubMed39198412
2024
hnRNP R promotes O-GlcNAcylation of eIF4G and facilitates axonal protein synthesis.
Applications
Unspecified application
Species
Unspecified reactive species
Abdolhossein Zare,Saeede Salehi,Jakob Bader,Cornelius Schneider,Utz Fischer,Alexander Veh,Panagiota Arampatzi,Matthias Mann,Michael Briese,Michael Sendtner
BioFactors (Oxford, England) 47:992-1015 PubMed34418170
2021
O-GlcNAcylation drives calcium signaling toward osteoblast differentiation: A bioinformatics-oriented study.
Applications
Unspecified application
Species
Unspecified reactive species
Yao Weng,Ziyi Wang,Yoko Fukuhara,Airi Tanai,Mika Ikegame,Daisuke Yamada,Takeshi Takarada,Takashi Izawa,Satoru Hayano,Kaya Yoshida,Hiroshi Kamioka,Hirohiko Okamura
Product promise
We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com